THE BEST SIDE OF SITUS JUDI MBL77

Not all people with CLL have to have therapy. Irrespective of all latest developments, the iwCLL even now recommends watchful observation for sufferers with asymptomatic disorder.86 This advice relies on no less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).10